+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Central Nervous System Drugs Market Research Reports

United States AUSTEDO Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

United States AUSTEDO Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • United States
From
Ingrezza Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Ingrezza Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
From
Frontotemporal Dementia (FTD) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Frontotemporal Dementia (FTD) - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 79 Pages
  • Global
From
TIGLUTIK, Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

TIGLUTIK, Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
CNM-Au8 Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

CNM-Au8 Emerging Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
From
From
From
From
From
From
Postherpetic Neuralgia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Postherpetic Neuralgia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Autism Spectrum Disorder (ASD) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Autism Spectrum Disorder (ASD) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Infantile Spasm - Epidemiology Forecast to 2032 - Product Thumbnail Image

Infantile Spasm - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
Neuroleptic Malignant Syndrome - Epidemiology Forecast - 2032 - Product Thumbnail Image

Neuroleptic Malignant Syndrome - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Loading Indicator

The Central Nervous System Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs that target the central nervous system. These drugs are used to treat a variety of conditions, including neurological disorders, mental health issues, and pain management. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. The Central Nervous System Drugs market is highly competitive, with companies competing to develop the most effective and safe treatments. Companies in the market are constantly researching and developing new drugs, as well as improving existing treatments. Many of these companies are also involved in clinical trials to test the safety and efficacy of their products. Some of the major companies in the Central Nervous System Drugs market include Pfizer, GlaxoSmithKline, Merck, Novartis, and Johnson & Johnson. These companies are involved in the development and production of a wide range of CNS drugs, including antidepressants, antipsychotics, and anticonvulsants. Show Less Read more